Covishield Vaccine side effects: AstraZeneca just ADMITTED IN COURT that their covid injection can cause a severe blood clot side effect. This is absolutely shocking news for everyone around the world.
The WHO has recognised TTS as a rare but serious adverse event linked to specific Covid-19 vaccines.
BOMBSHELL NEWS
AstraZeneca just ADMITTED IN COURT that their covid injection can cause a severe blood clot side effect.
This is absolutely huge news.
They are now being sued in a class action lawsuit from victims that have suffered after being lied to by the "experts" about… pic.twitter.com/4CcISuihLA
— PeterSweden (@PeterSweden7) April 29, 2024
Covishield Vaccine side effects
British pharmaceutical company AstraZeneca has admitted a big thing before the court. He admitted in court documents that his COVID-19 vaccine may have caused a rare side effect. This can also cause blood clots to form. AstraZeneca vaccine was also administered in India. According to Telegraph reported.
HIGHLIGHTS:-
- Pharma company AstraZeneca has admitted that its Covid-19 vaccine may cause TTS.
- He also said that it is extremely rare for this to happen because of the vaccine
- TTS can cause blood clots which can cause serious injury to the body.
🚨 For the first time, AstraZeneca has admitted that its COVID-19 vaccine can cause a rare side effect that causes blood clots and low platelet counts. pic.twitter.com/HHWFDdKp3I
— Indian Tech & Infra (@IndianTechGuide) April 30, 2024
Every person taking the Corona vaccine has been shaken by a revelation by British pharmaceutical company AstraZeneca. The vaccine manufacturer has admitted in court that Covishield can cause thrombosis with thrombocytopenia syndrome (TTS) in rare cases. AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. This can cause blood clots to form and reduce the platelet count. In severe cases of thrombocytopenia, it can also cause stroke and heart attack. Covishield, developed by AstraZeneca and Oxford University, was produced by the Serum Institute of India during the COVID-19 pandemic. This covid vaccine has been administered on a large scale in India also.
In the UK High Court, 51 cases are seeking damages of up to £100 million.
However, AstraZeneca has denied the lawyers’ claims that the vaccine is “defective” and its efficacy “vastly overstated”.
The UK government, which has secured AstraZeneca from legal action, is yet to intervene in the matter.